Invest with Grand Central Tech's Syndicate

Invest with Grand Central Tech

$173k

Typical Investments

Expected Deals/Year

Unique LPs have invested

Note from Grand Central Tech

GCT's Startup-in-Residence is a year long no equity, no rent program that gathers 20-25 of the premier pre-Series A companies in NYC, provides them with topflight growth resources and free workspace, allows them to build amongst a world-class peer founder network, expects them to abide by a shared set of values.

To date, 96 program companies have raised +$900mm from leading VCs over five years. The program is made possible by the Milstein family, top corporate partners including Google, Amazon, Microsoft, IBM, JP Morgan, Mastercard, GE, Lowe's, MRM/McCann, WSGR and over 100 incredible experts and advisors. 50% of GCT companies have been female-founded since inception.

Companies include: Common, Maven, Centivo, Knock, Timescale, Anvyl, Summer, NewtonX, Nomad Health, Eden Health, Otis, Nara Organics, Nautilus Labs, Hydra Studios, Hilma, Vowel, KidPass, Mattershift, Source3 (acq. FB), PulseData, Narrativ, AlphaPoint, Uru (acq. ADBE), Boom, Drawbridge Networks (acq. OPAQ), Stae, Republic, Cohero Health, Pinto, Concord Systems (acq. AKAM), Onward (acq. GOOG), Nextgenvest (acq. Common Bond), Ohmygreen, Lolli, Alphapoint.

Dealflow

This is a syndicate for Grand Central Tech SPV's

Team

Nelson Schubart

Matthew Harrigan

James Lovey

Investments

Maven Clinic

Common

NewtonX

Boom Entertainment

garten

Eden Health

Source3

Centivo

Private investments may not be included yet.
All deals on AngelList default to private. Learn More »

Grand Central Tech is a supervised person of or otherwise affiliated with Company Venture Capital Management, LLC, an “Exempt Reporting Adviser” under the Investment Advisers Act of 1940. Important information regarding Company Venture Capital Management, LLC, CRD Number 299250, can be found on its Form ADV available here. Grand Central Tech’s relationship with Company Venture Capital Management, LLC may give rise to potential conflicts of interest or conflicting duties, which could materially impact the performance any deals led by this syndicate.